{
  "docId": "019dd923-622c-750b-8b98-916758668d1f",
  "docSlug": "34401c2968d1",
  "documentTitle": "Dexcom, Inc. (DXCM)",
  "authorId": "54_Spruce_Point_Capital",
  "authorName": "Ben Axler",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2019-03-21 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 30,
  "pageCount": 83,
  "prevPage": 29,
  "nextPage": 31,
  "slideType": "before_after",
  "function": "diagnose_problem",
  "density": "overcrowded",
  "nDataPoints": 8,
  "notes": "Includes a quote from an Insulet earnings call as evidence of industry anticipation of interoperability.",
  "elementsJson": [
    "headline_text",
    "paragraph",
    "process_diagram",
    "quote_block",
    "data_table",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b98-916758668d1f/30",
  "deckHref": "/decks/019dd923-622c-750b-8b98-916758668d1f",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b98-916758668d1f.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-916758668d1f#slide-30",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "However, we believe that wider CGM compatibility sets up the industry for commoditization, and that Abbott is best positioned to benefit from this change as the low-cost provider.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-f5d2-7501-bd8a-327563fb9433",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.22,
        "w": 0.94,
        "x": 0.03,
        "y": 0.36
      },
      "kind": "diagram",
      "text": "Comparison of Old vs New FDA Approval Process",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9706a996-a454-49b6-a5e6-01f5c97f4a9d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "Total Market Opportunity: 72,200",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-f5d2-7501-bd8a-3a266bd0f95b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.94,
        "x": 0.03,
        "y": 0.16
      },
      "kind": "paragraph",
      "text": "Recent changes to the FDA's closed-loop system approval process encourage wider CGM-pump interoperability. Whereas, historically, the FDA would evaluate and approve a closed-loop system as a whole, it now evaluates and approves CGMs and pumps independently for use in generic closed-loop systems.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8c35e6ae-0bbc-4252-82bf-9467c0667c91",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.44,
        "x": 0.03,
        "y": 0.7
      },
      "kind": "quote",
      "text": "Can the Omnipod be configured with Libre 2.0 if they receive a high designation? Yes, that's a beautiful thing about this pathway that the FDA has created.",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8834e20f-aaea-4aa8-b23d-f4fd5e6e9136",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "\"Can the Omnipod be configured with Libre 2.0 if they receive a high designation?\" — Suraj Kalia, Analyst, Northland Securities; \"Yes, that's a beautiful thing about this pathway that the FDA has created. If they were able to reach special controls then certainly it could be a very easy clinical path to integration of their sensor in, for example, Horizon down the road.\" — Shacey Petrovic, President and CEO, Insulet Corporation",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd952-f5d2-7501-bd8a-37a8f7dc9675",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.35,
        "x": 0.01,
        "y": 0.97
      },
      "kind": "source-note",
      "text": "1. Source, 2. Source, 3. Spruce Point Estimate, 4. Spruce Point Estimate",
      "attrs": {
        "numbered": true
      },
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3bb54a71-8558-46a1-b3bd-30e8b5db76c7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.49,
        "x": 0.48,
        "y": 0.7
      },
      "kind": "table",
      "text": "Libre Market Opportunity Following Wider Insulin Pump Interoperability",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ef12229a-0ef4-49a1-9f5b-5ece5f42b275",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.65,
        "x": 0.31,
        "y": 0.03
      },
      "kind": "title",
      "text": "Universal CGM And Pump Interoperability Will Promote CGM Commoditization",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "58e065e5-e59e-4106-9b6d-5fddaaf764c5",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "before-after-framing",
      "slug": null,
      "matchId": "c9686a8e-b339-45b4-b361-1e624d2853ed",
      "evidence": "Comparison of old vs new FDA approval process",
      "confidence": 1
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}